Product Code: ANV1195
REPORT HIGHLIGHT
Generic Sterile Injectable Market size was valued at USD 79,058.1 million in 2022, expanding at a CAGR of 14.7% from 2023 to 2030.
The term "generic sterile injectable" refers to biologics that contain the same active ingredients as those found in the branded versions and are used to treat a range of medical conditions. However, its inactive components can vary from one another. The FDA (U.S. Administration of Food and Administration) regulates the production of generic sterile injectables, which are made in the same way as their commercial equivalents.
Generic Sterile Injectable Market- Market Dynamics:
Global geriatric population growth and the rising prevalence of different chronic diseases are the two main factors driving the market for generic sterile injectables. The market for generic sterile injectables is expanding because older people are more susceptible to various diseases and spend more money on healthcare. By 2050, the World Health Organization predicts that there will be about 2 billion older people in the world. Since some medications cannot be given orally, the use of injectable drug delivery has become more popular. For instance, the only way to administer the insulin used to control diabetes is through injections. The demand for generic sterile injectables is being driven by the rising prevalence of numerous chronic illnesses like cancer, diabetes, and cardiovascular diseases. In 2020, there were estimated to be 19.3 million new cases of cancer and 10 million cancer-related deaths, according to a study by the International Agency for Research on Cancer.
Generic Sterile Injectable Market- Segmentation Analysis:
Based on the product, the monoclonal segment is expected to dominate the market during the forecast period. The use of monoclonal antibodies in the therapy of conditions like cancer has spread quickly throughout the world. Without harming healthy cells, monoclonal antibodies can effectively cure infected cells while having little to no negative side effects. The market for monoclonal antibodies has increased significantly as a result.
Based on the distribution channel, the hospital segment is projected to dominate the market during the forecast period. The segment has grown significantly as a result of hospitals being used more frequently and a broad variety of generic sterile injectables being offered in hospital pharmacies.
Generic Sterile Injectable Market- Geographical Insights:
North America is expected to dominate the market during the forecast period. One of the main factors driving the growth of the North American generic sterile injectable market is the rise in non-communicable disease prevalence, the presence of a sizable geriatric population, improved access to healthcare facilities, increased awareness of the advantages of injectable drugs, and the rise in healthcare spending. According to estimates, more than half of the US populace has one or more chronic illnesses. Furthermore, by 2050, there will be 95 million elderly people living in the US. 18% of the US GDP is attributed to healthcare spending. These are the main components that have fueled industry expansion.
Generic Sterile Injectable Market- Recent Development:
In February 2022, Prochlorperazine Edisylate, a drug-infused similarly to other medications like Compazine injection of 10mg/2ml, was developed by Cosette Pharmaceuticals Inc. IT is used to manage nauseousness and regulate schizophrenia.
Key features of the study:
This proposed research study on the Generic Sterile Injectable market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
The research report elucidates potential growth opportunities across different segments/countries and explains an attractive investment proposition matrix for the Generic Sterile Injectable market
The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Generic Sterile Injectable market
The impact of COVID-19 on the Generic Sterile Injectable market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight into the Generic Sterile Injectable market post-COVID will also be covered.
To give the users of this report a comprehensive view of the Generic Sterile Injectable market, we have also included a competitive landscape and key innovator analysis for the Generic Sterile Injectable market.
The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
The report offers detailed company profiling featuring major market participants which will help users to understand the financial information and strategic initiatives of players operating in the Generic Sterile Injectable market.
In addition, the report also unveils the important acquisitions & mergers, collaborations & joint ventures, new launches, research & development, and regional expansion of major participants involved in the market on global as well as regional levels.
The global Generic Sterile Injectable market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL GENERIC STERILE INJECTABLE MARKET KEY PLAYERS:
Baxter
Fresenius Kabi
Civica
Pfizer
Teva
Hikma
Sandoz
Mylan
Nichi-Iko
3M
Merck & Co., Inc.
GLOBAL GENERIC STERILE INJECTABLE MARKET, BY PRODUCT:
Monoclonal Antibodies
Cytokines
Insulin
Peptide Hormones
Vaccines
Immunoglobulin
Blood Factors
Antibiotics
Others
GLOBAL GENERIC STERILE INJECTABLE MARKET, BY APPLICATION:
Cancer
Diabetes
Cardiovascular Disease
Central Nervous System
Musculoskeletal System
Others
GLOBAL GENERIC STERILE INJECTABLE MARKET, BY DISTRIBUTION CHANNEL:
Hospitals
Drug Stores
Retail Pharmacies
Others
GLOBAL GENERIC STERILE INJECTABLE MARKET, BY REGION:
North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA
TABLE OF CONTENT
1. Generic Sterile Injectable Market Overview
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Generic Sterile Injectable Market Snippet by Product
- 2.1.2. Generic Sterile Injectable Market Snippet by Application
- 2.1.3. Generic Sterile Injectable Market Snippet by Distribution Channel
- 2.1.4. Generic Sterile Injectable Market Snippet by Country
- 2.1.5. Generic Sterile Injectable Market Snippet by Region
- 2.2. Competitive Insights
3. Generic Sterile Injectable Key Market Trends
- 3.1. Generic Sterile Injectable Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Generic Sterile Injectable Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Generic Sterile Injectable Market Opportunities
- 3.4. Generic Sterile Injectable Market Future Trends
4. Generic Sterile Injectable Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Generic Sterile Injectable Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
6. Generic Sterile Injectable Market Landscape
- 6.1. Generic Sterile Injectable Market Share Analysis, 2022
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Generic Sterile Injectable Market - By Product
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Product, 2022 & 2030 (%)
- 7.1.2. Monoclonal Antibodies
- 7.1.3. Cytokines
- 7.1.4. Insulin
- 7.1.5. Peptide Hormones
- 7.1.6. Vaccines
- 7.1.7. Immunoglobulin
- 7.1.8. Blood Factors
- 7.1.9. Antibiotics
- 7.1.10. Others
8. Generic Sterile Injectable Market - By Application
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
- 8.1.2. Cancer
- 8.1.3. Diabetes
- 8.1.4. Cardiovascular Disease
- 8.1.5. Central Nervous System
- 8.1.6. Musculoskeletal System
- 8.1.7. Others
9. Generic Sterile Injectable Market - By Distribution Channel
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By Distribution Channel, 2022 & 2030 (%)
- 9.1.2. Hospitals
- 9.1.3. Drug Stores
- 9.1.4. Retail Pharmacies
- 9.1.5. Others
10. Generic Sterile Injectable Market- By Geography
- 10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
- 10.2. North America
- 10.2.1. Overview
- 10.2.2. Generic Sterile Injectable Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.2.7. U.S.
- 10.2.7.1. Overview
- 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.2.7.3. U.S. Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.2.7.5. U.S. Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.2.8. Canada
- 10.2.8.1. Overview
- 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.2.8.3. Canada Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.2.8.5. Canada Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.3. Europe
- 10.3.1. Overview
- 10.3.2. Generic Sterile Injectable Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.3.7. Germany
- 10.3.7.1. Overview
- 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.7.3. Germany Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.7.5. Germany Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.3.8. Italy
- 10.3.8.1. Overview
- 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.8.3. Italy Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.8.5. Italy Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.3.9. United Kingdom
- 10.3.9.1. Overview
- 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.9.3. United Kingdom Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.9.5. United Kingdom Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.3.10. France
- 10.3.10.1. Overview
- 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.10.3. France Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.10.5. France Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.3.11. Russia
- 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.11.2. Russia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.11.4. Russia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.3.12. Netherlands
- 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.12.2. Netherlands Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.12.4. Netherlands Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.3.13. Sweden
- 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.13.2. Sweden Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.13.4. Sweden Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.3.14. Poland
- 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.14.2. Poland Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.14.4. Poland Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.3.15. Rest of Europe
- 10.3.15.1. Overview
- 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Generic Sterile Injectable Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.4.7. India
- 10.4.7.1. Overview
- 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.7.3. India Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.7.5. India Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.4.8. China
- 10.4.8.1. Overview
- 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.8.3. China Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.8.5. China Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.4.9. Japan
- 10.4.9.1. Overview
- 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.9.3. Japan Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.9.5. Japan Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.4.10. South Korea
- 10.4.10.1. Overview
- 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.10.3. South Korea Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.10.5. South Korea Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.4.11. Australia
- 10.4.11.1. Overview
- 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.11.3. Australia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.11.5. Australia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.4.12. Thailand
- 10.4.12.1. Overview
- 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.12.3. Thailand Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.12.5. Thailand Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.4.13. Indonesia
- 10.4.13.1. Overview
- 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.13.3. Indonesia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.13.5. Indonesia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.4.14. Philippines
- 10.4.14.1. Overview
- 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.14.3. Philippines Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.14.5. Philippines Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.4.15. Rest of APAC
- 10.4.15.1. Overview
- 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Generic Sterile Injectable Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.5.7. Brazil
- 10.5.7.1. Overview
- 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.7.3. Brazil Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.5.7.5. Brazil Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.5.8. Mexico
- 10.5.8.1. Overview
- 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.8.3. Mexico Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.5.8.5. Mexico Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.5.9. Argentina
- 10.5.9.1. Overview
- 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.9.3. Argentina Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.5.9.5. Argentina Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.5.10. Colombia
- 10.5.10.1. Overview
- 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.10.3. Colombia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.5.10.5. Colombia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.5.11. Rest of LATAM
- 10.5.11.1. Overview
- 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Generic Sterile Injectable Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.6.7. Saudi Arabia
- 10.6.7.1. Overview
- 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.6.8. United Arab Emirates
- 10.6.8.1. Overview
- 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.6.9. Israel
- 10.6.9.1. Overview
- 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.9.3. Israel Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.9.5. Israel Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.6.10. Turkey
- 10.6.10.1. Overview
- 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.10.3. Turkey Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.10.5. Turkey Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.6.11. Algeria
- 10.6.11.1. Overview
- 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.11.3. Algeria Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.11.5. Algeria Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.6.12. Egypt
- 10.6.12.1. Overview
- 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.12.3. Egypt Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.12.5. Egypt Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.6.13. Rest of MEA
- 10.6.13.1. Overview
- 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
11. Key Vendor Analysis- Generic Sterile Injectable Industry
- 11.1. Competitive Dashboard
- 11.2. Company Profiles
- 11.2.1. Baxter
- 11.2.2. Fresenius Kabi
- 11.2.3. Civica
- 11.2.4. Pfizer
- 11.2.5. Teva
- 11.2.6. Hikma
- 11.2.7. Sandoz
- 11.2.8. Mylan
- 11.2.9. Nichi-Iko
- 11.2.10. 3M
- 11.2.11. Merck & Co., Inc.
12. 360 Degree Analyst View
13. Appendix
- 13.1. Research Methodology
- 13.2. References
- 13.3. Abbreviations
- 13.4. Disclaimer
- 13.5. Contact Us